Erectile dysfunction in methadone maintenance patients: a cross sectional study in northern iran.

  • Seyed Hamzeh Hosseini Department of Psychiatry, Psychiatry and Behavioral Sciences Research Center, Mazandaran University of Medical Sciences, Sari, Iran
  • Ali Isapour Department of Urology, Mazandaran University of Medical Sciences, Sari, Iran
  • Mehrdad Tavakoli Mazandaran University of Medical Sciences, Sari, Iran
  • Mehrdad Taghipour Baqiatallah University of Medical Sciences, Tehran, Iran
  • Meysam Rasuli Mazandaran University of Medical Sciences, Sari, Iran
Keywords: Drug Abusing, Erectile Dysfunction, Methadone

Abstract

Objective: Erectile dysfunction affects quality of life and is a common dysfunction in drug abusers. The aim of this study was to evaluate the frequency of erectile dysfunction in drug abusers on methadone maintenance therapy to reduce this drug side effect in the future studies .
Methods: This cross-sectional study was conducted with two hundred addicted individuals on methadone maintenance therapy. Erectile dysfunction was surveyed using the International Index of Erectile Function (IIEF). Finally, all data were collected and analyzed by descriptive statistics such as measures of variability and central tendency and Chi-squared (χ²) test using SPSS Version18.0 software .
Results: The amount of the total frequency of erectile dysfunction was pointed 30 or less among the two hundred patients and included the moderate and severe cases. In this study, the number of patients with erectile dysfunction was fifty three (26.5%).
Conclusion: The frequency of erectile dysfunction in our study was approximately 1.5 tim s of prevalence of the public (16.1%). In this study, all the factors related to sexual function such as erectile function, libido, orgasm, and sexual pleasure showed a decline among drug abusers.

References

E Ricci, F Parazzini, V Mirone, C Imbimbo, A Palmieri, A Bortolotti, et al. Current drug use as risk factor for erectile dysfunction: results from an Italian epidemiological study. International Journal of Impotence Research 2003; 15: 221–224.

Selvin E, Burnett AL, Platz EA. Prevalence and Risk Factors for Erectile Dysfunction in the Us. Am J Med 2007; 120: 151-157.

Kantor J, Bilker WB, Glasser DB, Margolis DJ. Prevalence of Erectile Dysfunction and Active Depression: An Analytic Cross-Sectional Study of General Medical Patients. Am J Epidemiol 2002; 156: 1035-1042.

Hallinan R, Byrne A, Agho K, McMahon C, Tynan P, Attia J. Erectile dysfunction in men receiving methadone and buprenorphine maintenance treatment. J Sex Med 2008; 5: 684-92.

Daniell HW. Hypogonadism in men consuming sustained-action oral opioids. J Pain 2002; 3: 377-84.

Bruera E, Palmer JL, Bosnjak S, Rico MA, Moyano J, Sweeney C, et al. Methadone Versus Morphine as a First-Line Strong Opioid for Cancer Pain: A Randomized, Double-Blind Study. J Clin Oncol 2004; 22: 185-192.

Inturrisi CE. Pharmacology of Methadone and Its Isomers. Minerva anestesiologica 2005; 71: 435-437.

Mirone V, Imbimbo C, Bortolotti A, Di Cintio E, Colli E, Landoni M, et al. Cigarette Smoking as Risk Factor for Erectile Dysfunction: Results from an Italian Epidemiological Study. European urology 2002; 41: 294-297.

Nicolosi A, Laumann EO, Glasser DB, Moreira ED, Jr., Paik A, Gingell C, et al. Sexual Behavior and Sexual Dysfunctions after Age 40: The Global Study of Sexual Attitudes and Behaviors. Urology 2004; 64: 991-997.

Sasaki H, Yamasaki H, Ogawa K, Nanjo K, Kawamori R, Iwamoto Y, et al. Prevalence and Risk Factors for Erectile Dysfunction in Japanese Diabetics. Diabetes research and clinical practice 2005; 70: 81-89.

Krishnan R, Izatt S, Bargman JM, Oreopoulos D. Prevalence and Determinants of Erectile Dysfunction in Patients on Peritoneal Dialysis. International urology and nephrology 2003; 35: 553-556.

Al-Gommer O, George S, Haque S, Moselhy H, SaravanappaT. Sexual dysfunctions in male opiate users: A comparative study of heroin, methadone, and buprenorphine. Addictive Disorders & Their Treatment 2007; 6: 137–143.

Brown R, Balousek S, Mundt M, Fleming M. Methadone Maintenance and Male Sexual Dysfunction. Journal of addictive diseases 2005; 24: 91-106.

Reece AS. Differing Age Related Trajectories of Dysfunction in Several Organ Systems in Opiate Dependence. Aging Clin Exp Res 2012; 24: 85-96.

Quaglio G, Lugoboni F, Pattaro C, Melara B, G.I.C.S, Mezzelani P, et al. Erectile Dysfunction in Male Heroin Users, Receiving Methadone and Buprenorphine Maintenance Treatment. Drug Alcohol Depend 2008; 94: 12-18.

Parazzini F, Menchini Fabris F, Bortolotti A, Calabro A, Chatenoud L, Colli E, et al. Frequency and Determinants of Erectile Dysfunction in Italy. Eur Urol 2000; 37: 43-49.

Giacomuzzi SM, Khreis A, Riemer Y, Garber K, Ertl M. Buprenorphine and Methadone Maintenance Treatment - Sexual Behaviour and Dysfunction Prevalence. Letters in Drug Design & Discovery 2009; 6: 13.

Chekuri V, Gerber D, Brodie A, Krishnadas R. Premature ejaculation and other sexual dysfunctions in opiate dependent men receiving methadone substitution treatment. Addictive Behaviors 2012; 37: 124–126.

Palha AP, Esteves M. A study of the sexuality of opiate addicts. J Sex Marital Ther 2002; 28: 427-37.

Bang-Ping J. Sexual Dysfunction in Men Who Abuse Illicit Drugs: A Preliminary Report. J Sex Med 2009; 6: 1072-1080.

He J, Reynolds K, Chen J, Chen CS, Wu X, Duan X, et al. Cigarette Smoking and Erectile Dysfunction among Chinese Men without Clinical Vascular Disease. Am J Epidemiol 2007; 166: 803-809.

Tengs TO, Osgood ND. The Link between Smoking and Impotence: Two Decades of Evidence. Prev Med 2001; 32: 447-452.

Wolf R, Shulmam A. Erectile dysfunction and fertility related to cigarette smoking. J Eur Acad Dermatol Venereol 1996; 6: 209-16.

McKay A. Sexuality and substance use: the impact of tobacco, alcohol and selected recreational drugs on sexual function. Can J Hum Sex 2005; 14: 47-56.

O’Farrell TJ, Kleinke CL, Cutter HS. Sexual adjustment of male alcoholics: changes from before to after receiving alcoholism counseling with and without marital therapy. Addict Behav 1998; 23: 419-425.

Peugh J, Belenko S. Alcohol, drugs and sexual function: a review. J Psychoactive Drugs 2001; 33: 223-32.

Hirshfield S, Remien RH, Walavalkar I, Chiasson MA. Crystal Methamphetamine Use Predicts Incident Std Infection among Men Who Have Sex with Men Recruited Online: A Nested Case-Control Study. Journal of medical Internet research 2004; 6: e41.

Zemishlany Z, Aizenberg D, Weizman A. Subjective Effects of Mdma ('Ecstasy') on Human Sexual Function. Eur Psychiatry 2001; 16: 127-130.

Saso L. Effects of drug abuse on sexual response. Ann Ist Super Sanità 2002; 38: 289-96.

Mireku-Boateng AO, Tasie B. Priapism Associated with Intracavernosal Injection of Cocaine. Urol Int 2001; 67: 109-110.

MacDonald PT, Waldorf D, Reinarman C, Murphy S. Heavy cocaine use and sexual behavior. J Drug Issues 1988; 18: 437-55.

Adams IB, Martin BR. Cannabis: pharmacology and toxicology in animals and humans. Addiction 1996; 91: 1585-1614.

Gonzáles AI, Sties SW, Wittkopf PG, Mara LS, Ulbrich AZ, Cardoso FL, Carvalho TD. Validation of the International Index of Erectile Function (IIFE) for use in Brazil. Arq Bras Cardiol 2013. pii: S0066- 782X2013005000051.

Mofid A, Seyedalinaghi SA, Zandieh S, Yazdani T, Jam S. Prevalence and Risk Factors of Erectile Dysfunction in Iranian Diabetic Men. Acta Medica Iranica 2009; 47: 309-314.

How to Cite
1.
Hosseini SH, Isapour A, Tavakoli M, Taghipour M, Rasuli M. Erectile dysfunction in methadone maintenance patients: a cross sectional study in northern iran. Iran J Psychiatry. 8(4):172-8.
Section
Articles